Orion Biotech Opportunities (Orion Biotech Opportunities) Debt-to-Revenue : N/A (As of Dec. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Orion Biotech Opportunities Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Orion Biotech Opportunities's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was $0.00 Mil. Orion Biotech Opportunities's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was $0.00 Mil. Orion Biotech Opportunities's annualized Revenue for the quarter that ended in Dec. 2022 was $0.00 Mil.

Orion Biotech Opportunities Debt-to-Revenue Historical Data

The historical data trend for Orion Biotech Opportunities's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Biotech Opportunities Debt-to-Revenue Chart

Orion Biotech Opportunities Annual Data

Trend

Dec21

Dec22

Debt-to-Revenue

N/A

Orion Biotech Opportunities Quarterly Data
	Feb21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Debt-to-Revenue	Get a 7-Day Free Trial			N/A	N/A	N/A	N/A	N/A

Competitive Comparison of Orion Biotech Opportunities's Debt-to-Revenue

For the Shell Companies subindustry, Orion Biotech Opportunities's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orion Biotech Opportunities's Debt-to-Revenue Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Orion Biotech Opportunities's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Orion Biotech Opportunities's Debt-to-Revenue falls into.

Orion Biotech Opportunities Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Orion Biotech Opportunities's Debt-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	0)	/	N/A
	=	N/A

Orion Biotech Opportunities's annualized Debt-to-Revenue for the quarter that ended in Dec. 2022 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0	+	0)	/	0
	=	N/A

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2022) Revenue data.

Orion Biotech Opportunities Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Orion Biotech Opportunities's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.